查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1448021

牛初乳市场 - 2023-2030

Cow Colostrum Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 210 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2022年，全球牛初乳市场达到12亿美元，预计2030年将达到18亿美元，2023-2030年预测期间CAGR为5.2%。

预计 2024 年至 2031 年期间，对牛初乳的需求将显着上升，

由于牛初乳卓越的营养成分和高水平的抗体，消费者越来越多地将牛初乳纳入各种应用，特别是婴儿产品中。这些抗体在预防感染和促进婴儿和动物的健康成长方面发挥着至关重要的作用。此外，牛初乳因其丰富的必需营养素和蛋白质而受到重视。

此外，製造公司正在透过引入创新的牛初乳产品来实现产品组合多元化，这项策略旨在扩大其市场规模并扩大其市场占有率。例如，2022年11月，PanTheryx公司推出了新的Life's First Naturals PRO牛初乳补充剂，它由免疫因子、保护性蛋白质、生长因子和益生元的综合来源ColostrumOne提供动力。

营养和膳食补充剂领域在全球牛初乳市场中占最大份额。同样，亚太地区一直是主导力量，因为该地区的牛奶生产率很高，而且製造商也在开发创新的牛初乳产品，这有助于推动全球牛初乳市场。

动力学

初乳腺癌盛行率增加

益生菌紊乱可导致初乳腺癌，而消费者中初乳腺癌的盛行率正在上升。例如，根据世界卫生组织 (WHO) 的报告，大肠癌是全球第三大常见癌症，约占所有癌症病例的 10%，也是全球癌症相关死亡的第二大原因。它主要影响老年人，大多数病例发生在 50 岁及以上的人群中。

此外，製造公司正致力于开发各种产品以吸引更大的消费者群。例如，2022年11月，APS Bio Group和Sunplus宣布建立多年策略伙伴关係，共同开发新的牛初乳产品。透过此策略合作，APS 将在 sunplus 的 natrapure cbps 奶粉中首次推​​出其新的初乳碱性蛋白和免疫球蛋白配方。

增加产品开发

产品开发人员正在将牛初乳添加到各种功能性食品和膳食补充剂中，因为牛初乳以其高营养含量（包括蛋白质和维生素）而闻名。它提供有助于免疫系统支持的抗体。因此，产品开发有助于推动全球牛初乳市场。

此外，各大公司都在策略性地开发和扩大初乳市场。例如，2022 年 12 月，Blendhub 和 ColoPlus AB 之间的合作创新推出了基于牛初乳的 ColoPlus 配方，帮助癌症或爱滋病患者、顶级运动员或老年人恢復免疫系统。此次合作旨在开发和商业化基于牛初乳和天然营养的生物活性特性的专利创新营养食品。

乳糖不耐症

有些消费者可能无法消化乳糖，他们无法消化以牛初乳为基础的产品。乳糖不耐症的盛行率正在增加，例如，根据 2023 年的医药报告，大约 65% 的人口在婴儿期后消化乳糖的能力下降，这在东亚地区最为常见。因此，如此高的盛行率可能会限制较小消费群的市场。

目录

目录

第 1 章：方法与范围

  • 研究方法论
  • 报告的研究目的和范围

第 2 章：定义与概述

第 3 章：执行摘要

  • 自然片段
  • 按产品类型分類的片段
  • 按应用程式片段
  • 按配销通路分類的片段
  • 按地区分類的片段

第 4 章：动力学

  • 影响因素
    • 司机
      • 初乳腺癌盛行率增加
      • 增加产品开发
    • 限制
      • 乳糖不耐症
    • 机会
    • 影响分析

第 5 章：产业分析

  • 波特五力分析
  • 供应链分析
  • 定价分析
  • 监管分析
  • DMI 意见

第 6 章：COVID-19 分析

  • COVID-19 分析
    • 新冠疫情爆发前的情景
    • 新冠疫情期间的情景
    • 新冠疫情后的情景
  • COVID-19 期间的定价动态
  • 供需谱
  • 疫情期间政府与市场相关的倡议
  • 製造商策略倡议
  • 结论

第 7 章：本质

  • 有机的
  • 传统的

第 8 章：依产品类型

  • 所有的
    • 全牛初乳粉
    • 脱脂初乳粉
    • 特种牛初乳粉
  • 初乳成品
    • 胶囊
    • 咀嚼片
    • 独立小袋
    • 特殊配方产品

第 9 章：按应用

  • 食物
  • 化妆品
  • 营养和膳食补充剂
  • 其他的

第 10 章：按配销通路

  • 大型超市/超市
  • 便利商店
  • 专卖店
  • 药局
  • 其他的

第 11 章：按地区

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 俄罗斯
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 澳洲
    • 亚太其他地区
  • 中东和非洲

第 12 章：竞争格局

  • 竞争场景
  • 市场定位/份额分析
  • 併购分析

第 13 章：公司简介

  • Colostrum BioTec GmbH
    • 公司简介
    • 产品组合和描述
    • 财务概览
    • 主要进展
  • Zuche Pharmaceuticals.
  • Biodane Pharma A/S
  • Agati Healthcare
  • mcePharma
  • Cure Nutraceutical PVT. LTD.
  • PanTheryx, Inc.
  • NOW Health Group, Inc.
  • Sterling Technology
  • Aadvik Foods

第 14 章：附录

简介目录
Product Code: FB8082

Overview

Global Cow Colostrum Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.8 billion by 2030, growing with a CAGR of 5.2% during the forecast period 2023-2030.

The demand for cow colostrum is rising significantly over the forecast period of 2024-2031,

Consumers are increasingly incorporating cow colostrum into a variety of applications, particularly in infant products, due to its exceptional nutritional content and high levels of antibodies. These antibodies play a crucial role to safeguard against infections and promoting healthy growth in both infants and animals. Additionally, cow colostrum is valued for its abundance of essential nutrients and proteins.

In addition, manufacturing companies are diversifying their portfolios by introducing innovative cow colostrum products, a strategy aimed at increasing their market sizes and expanding their market presence. For instance, in November 2022, PanTheryxcompany launched a new Life's First Naturals PRO bovine (cow) colostrum supplement, it is powered by ColostrumOne, a comprehensive source of immune factors, protective proteins, growth factors, and prebiotics.

The nutritional and dietary supplements segment accounts the largest share in global cow colostrum market. Similarly, Asia-Pacific region has been a dominant force as the production rate of milk is high in this region, as well as manufactures also developing innovative cow colostrum products, which can help in driving the global cow colostrum market.

Dynamics

Increasing Prevalence Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with the majority of cases occurring in people aged 50 and above.

In addition, manufacturing companies are focusing on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS Bio Group and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Increase in Product Development

Product developers are incorporating cow colostrum into various functional foods and dietary supplements, as cow colostrum is known for its high nutritional content, including proteins, and vitamins. It offers antibodies that contribute to immune system support. As a result product development can help in driving the global cow colostrum market.

Furthermore, major companies are strategically developing and expanding the colostrum market. For instance, in December 2022, collaborative innovation between Blendhub and ColoPlus AB launched a ColoPlus formula based on bovine colostrum to help restore the immune system in cancer or HIV patients, top athletes, or the elderly. This collaboration is to develop and commercialize patented innovative nutraceutical food products based on the bioactive properties of bovine colostrum and natural nutrition.

Lactose Intolerance

Some consumers might have an inability to digest the lactose, they are unable to digest cow-colostrum-based products. The prevalence of lactose intolerance is increasing, for instance, according to a pharma report of 2023, approximately 65 percent of the human population has a reduced ability to digest lactose after infancy, and it is most common in the East Asian region. Therefore, such a high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global cow colostrum market is segmented based on nature, product type, application, distribution channel, and region.

Increase in Demand for Effective Natural Organic Nutritional and Dietary Supplements

The nutritional and dietary supplements segment accounts for the largest share of the global cow colostrum market, consumers are adopting these cow colostrum as they are rich in immunoglobulins, antibodies that play a vital role in supporting the immune system. The regular consumption of colostrum supplements may help enhance the body's defense mechanisms against infections and illnesses.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, the Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. It helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production, and Product Development

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

In addition, the manufacturing companies in this region are also launching products to support the rising market demand. For instance, in May 2020, the Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, mcePharma, Cure Nutraceutical PVT. LTD., PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Aadvik Foods.

COVID-19 Impact Analysis

The pandemic has had diverse effects on various markets, including the food and healthcare sectors. Many governments have imposed lockdown restrictions which has disrupted the supply chain, changes in consumer behavior, and economic challenges can influence markets. Hence, COVID-19 has shown a negative impact global cow colostrum market.

By Nature

  • Organic
  • Conventional

By Product Type

  • Whole
  • Whole Colostrum Powder
  • Skim Colostrum Powder
  • Specialty Colostrum Powder
  • Colostrum Finished Products
  • Capsules
  • Chewable Tablets
  • Individual Sachets
  • Specially Formulated Products

By Application

  • Food
  • Cosmetics
  • Nutritional and Dietary Supplements
  • Others

By Distribution Channel

  • Hypermarket/Supermarket
  • Convenience Store
  • Specialty Stores
  • Drug Stores
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • Rest of Asia-Pacific
  • Middle East and Africa

Key Developments

  • In May 2022, Glanbia Nutritionals acquired Sterling Technology, a South Dakota-based manufacturer of dairy bioactive solutions derived from bovine colostrum. Glanbia Nutritionals purchased for $60 million plus deferred consideration.
  • In November 2022, PanTheryx launches extra- strength colostrum supplement which is Life's First Naturals PRO, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

Why Purchase the Report?

  • To visualize the global cow colostrum market segmentation based on nature, product type, application, distribution channel, and region, as well as understand key commercial assets and players.
  • Identify commercial opportunities by analyzing trends and co-development.
  • Excel data sheet with numerous data points of cow colostrum market-level with all segments.
  • PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
  • Product mapping available as Excel consisting of key products of all the major players.

The global cow colostrum market report would provide approximately 70 tables, 63 figures and 210 Pages.

Target Audience 2023

  • Manufacturers/ Buyers
  • Industry Investors/Investment Bankers
  • Research Professionals
  • Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

  • 1.1.Research Methodology
  • 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

  • 3.1.Snippet by Nature
  • 3.2.Snippet by Product Type
  • 3.3.Snippet by Application
  • 3.4.Snippet by Distribution Channel
  • 3.5.Snippet by Region

4.Dynamics

  • 4.1.Impacting Factors
    • 4.1.1.Drivers
      • 4.1.1.1.Increasing Prevalence of Colostrum Cancers
      • 4.1.1.2.Increase in Product Development
    • 4.1.2.Restraints
      • 4.1.2.1.Lactose Intolerance
    • 4.1.3.Opportunity
    • 4.1.4.Impact Analysis

5.Industry Analysis

  • 5.1.Porter's Five Force Analysis
  • 5.2.Supply Chain Analysis
  • 5.3.Pricing Analysis
  • 5.4.Regulatory Analysis
  • 5.5.DMI Opinion

6.COVID-19 Analysis

  • 6.1.Analysis of COVID-19
    • 6.1.1.Scenario Before COVID
    • 6.1.2.Scenario During COVID
    • 6.1.3.Scenario Post COVID
  • 6.2.Pricing Dynamics Amid COVID-19
  • 6.3.Demand-Supply Spectrum
  • 6.4.Government Initiatives Related to the Market During Pandemic
  • 6.5.Manufacturers Strategic Initiatives
  • 6.6.Conclusion

7.By Nature

  • 7.1.Introduction
    • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 7.1.2.Market Attractiveness Index, By Nature
  • 7.2.Organic*
    • 7.2.1.Introduction
    • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3.Conventional

8.By Product Type

  • 8.1.Introduction
    • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 8.1.2.Market Attractiveness Index, By Product Type
  • 8.2.Whole*
    • 8.2.1.Introduction
    • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 8.2.3.Whole Colostrum Powder
    • 8.2.4. Skim Colostrum Powder
    • 8.2.5. Specialty Colostrum Powder
  • 8.3.Colostrum Finished Products
    • 8.3.1.Capsules
    • 8.3.2.Chewable Tablets
    • 8.3.3.Individual Sachets
    • 8.3.4. Specially Formulated Products

9.By Application

  • 9.1.Introduction
    • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2.Market Attractiveness Index, By Application
  • 9.2.Food*
    • 9.2.1.Introduction
    • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3.Cosmetics
  • 9.4.Nutritional and Dietary Supplements
  • 9.5.Others

10.By Distribution Channel

  • 10.1.Introduction
    • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 10.1.2.Market Attractiveness Index, By Distribution Channel
  • 10.2.Hypermarket/Supermarket*
    • 10.2.1.Introduction
    • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 10.3.Convenience Store
  • 10.4.Specialty Stores
  • 10.5.Drug Stores
  • 10.6.Others

11.By Region

  • 11.1.Introduction
    • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 11.1.2.Market Attractiveness Index, By Region
  • 11.2.North America
    • 11.2.1.Introduction
    • 11.2.2.Key Region-Specific Dynamics
    • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1.U.S.
      • 11.2.7.2.Canada
      • 11.2.7.3.Mexico
  • 11.3.Europe
    • 11.3.1.Introduction
    • 11.3.2.Key Region-Specific Dynamics
    • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1.Germany
      • 11.3.7.2.UK
      • 11.3.7.3.France
      • 11.3.7.4.Italy
      • 11.3.7.5.Russia
      • 11.3.7.6.Rest of Europe
  • 11.4.South America
    • 11.4.1.Introduction
    • 11.4.2.Key Region-Specific Dynamics
    • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1.Brazil
      • 11.4.7.2.Argentina
      • 11.4.7.3.Rest of South America
  • 11.5.Asia-Pacific
    • 11.5.1.Introduction
    • 11.5.2.Key Region-Specific Dynamics
    • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
    • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1.China
      • 11.5.7.2.India
      • 11.5.7.3.Japan
      • 11.5.7.4.Australia
      • 11.5.7.5.Rest of Asia-Pacific
  • 11.6.Middle East and Africa
    • 11.6.1.Introduction
    • 11.6.2.Key Region-Specific Dynamics
    • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
    • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

  • 12.1.Competitive Scenario
  • 12.2.Market Positioning/Share Analysis
  • 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

  • 13.1.Colostrum BioTec GmbH*
    • 13.1.1.Company Overview
    • 13.1.2.Product Portfolio and Description
    • 13.1.3.Financial Overview
    • 13.1.4.Key Developments
  • 13.2.Zuche Pharmaceuticals.
  • 13.3.Biodane Pharma A/S
  • 13.4.Agati Healthcare
  • 13.5.mcePharma
  • 13.6.Cure Nutraceutical PVT. LTD.
  • 13.7.PanTheryx, Inc.
  • 13.8.NOW Health Group, Inc.
  • 13.9.Sterling Technology
  • 13.10.Aadvik Foods

LIST NOT EXHAUSTIVE

14.Appendix

  • 14.1.About Us and Services
  • 14.2.Contact Us